Pan-cancer analysis showed that the expression of THEM6 was associated with immunomodulators, such as immunostimulators (Figure 1(c)), MHC molecules (Figure 1(d)), chemokines (Figure 1(e)), and receptors (Figure 1(f)) in most tumors, despite varied correlations among different cancers. This evidence concerns the gene THEM6 and cancer.